These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results

Merit Medical Systems, Inc. (NASDAQ:MMSI) on Thursday reported upbeat results for the third quarter.

The company posted quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.03 per share. The company reported quarterly sales of $416.244 million which beat the analyst consensus estimate of $410.376 million.

Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.25-$4.35 to $4.33-$4.37 and narrowed sales guidance from $1.631 billion-$1.643 billion to $1.635 billion-$1.642 billion.

“Merit delivered third quarter financial results that exceeded the high end of our expectations, driven primarily by 9% organic, constant currency revenue growth, excluding the impact of a strategic divestiture,” said Martha G. Aronson, Merit’s President and CEO.

Merit Medical Systems shares rose 0.1% to $93.40 in pre-market trading

These analysts made changes to their price targets on Merit Medical Systems following earnings announcement.

• BTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $105 to $110.
• Needham analyst Mike Matson maintained the stock with a Buy and raised the price target from $101 to $106.

Considering buying MMSI stock? Here’s what analysts think:

Photo via Shutterstock